Objectives Dengue infection is spreading worldwide. The clinical spectrum is broad and
includes asymptomatic infections. This review provides an overview of the different …

Although antiviral antibodies generally confer protective functions, antibodies against
dengue virus (DENV) are associated with enhanced disease susceptibility. Antibodies can …

Cities worldwide are facing ever-increasing pressure to develop mitigation strategies for all
sectors to deal with the impacts of climate change. Cities are expected to house 70% of the …

Although it is known that household infections drive the transmission of dengue virus
(DENV), it is unclear how household composition and the immune status of inhabitants affect …

Background Dengue infection is a global health threat. While symptomatic cases contribute
to morbidity and mortality, the majority of infected people are asymptomatic but serve as an …

The clinical outcome of DENV and other Flaviviruses infections represents a spectrum of
severity that ranges from mild manifestations to severe disease, which can ultimately lead to …

Dengue is endemic in Bangladesh and is an important cause of morbidity and mortality.
Suppressing the mosquito vector activity at the optimal time annually is a practical strategy to …

Heterotypic secondary dengue virus (DENV) infection is a risk factor for the development of
severe disease. To assess the contribution of the developing polyclonal humoral immune …

Japanese encephalitis virus (JEV) is the main cause of human viral encephalitis in Asia, with
a mortality rate reaching 30%, mostly affecting children. The traditionally described cycle …

Introducción: el dengue es la arbovirosis de propagación más rápida en todo el mundo;
anualmente 390 millones de personas son infectadas. Objetivo: identificar las …